Tennessee Oncology NASH - SCRI — Nashville, Tennessee

Tennessee Oncology NASH - SCRI is a clinical research site located in Nashville, Tennessee, United States 37203.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

Tennessee Oncology NASH - SCRI has participated in 1 clinical trials.

Therapeutic areas: Select Advanced Solid Tumors.

Sponsors: Immunocore Ltd.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Tennessee Oncology NASH - SCRI?

Tennessee Oncology NASH - SCRI has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Tennessee Oncology NASH - SCRI conducted?

Tennessee Oncology NASH - SCRI has 1 clinical trials on record. Their work covers Select Advanced Solid Tumors.

Is Tennessee Oncology NASH - SCRI accredited by Crixeo Health?

Tennessee Oncology NASH - SCRI has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Tennessee Oncology NASH - SCRI?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.